Table 2.
Patient | Typea | Electromyography | Muscular biopsy | Nerve biopsy | ||||||||||||
Concentric needle examinatioin | Motor nerve conduction | Sensory nerve conduction | Atrophy | Necrosis | Myosin loss | Axonal degeneration | Demyelination | |||||||||
FP | LP | Recruitmentb | ||||||||||||||
0 | 1 | 2 | 3 | CV (m/s) | CMAP (mV) | CV (m/s) | CMAP (µV) | |||||||||
1 | N | + | + | Peroneal 46/ulnar 68 | 1/0.1 | I/II | + | |||||||||
2 | N | + | + | Peroneal 0/median 0 | 0/0 | Sural 0/radial 0 | 0/0 | II | + | + | ||||||
3 | N | + | + | + | Peroneal 33 | 0.1 | Peroneal 41 | 10 | I | + | + | |||||
4 | N | + | + | Peroneal 26/median 37 | 1/1 | Peroneal 35/median 38 | 2/1 | I/II | + | + | ||||||
5 | N | + | + | + | Peroneal 41 | 3 | Peroneal 33 | 4 | I/II | + | + | + | ||||
6 | N | + | + | + | Peroneal 40 | 2 | Peroneal 36/radial 48 | 7/48 | I/II | + | + | + | ||||
7 | NM | + | + | Peroneal 0 | 0 | Peroneal 0 | 0 | I/II | + | + | + | |||||
8 | NM | + | + | Peroneal 0 | 0 | Peroneal 0 | 0 | I/II | + | + | + | |||||
9 | NM | + | + | + | Peroneal 38 | 0.1 | Peroneal 35/radial 48 | 3/8 | I/II | + | + | + | ||||
10 | M | + | + | + | + | Peroneal 36/median 34 | 0.8/0.8 | Peroneal 52/radial 56 | 7/16 | II | + | + | No | No | ||
11 | M | + | Peroneal 42 | 1.6 | Peroneal 58 | 12 | II | + | No | No | ||||||
12 | M | + | + | Peroneal 35 | 1.2 | Peroneal 43/radial 43 | 20/22 | I/II | + | No | No | |||||
13 | M | + | Peroneal 39 | 0.8 | Peroneal 42 | 24 | II | + | No | No | ||||||
14 | M | + | + | + | + | Peroneal 43 | 1.6 | Peroneal 44 | 12 | II | + | + | No | No | ||
15 | M | + | + | Peroneal 40 | 1.0 | Peroneal 42 | 7 | II | + | No | No |
aType of neurological lesion. bRecruitment (muscular contraction): 0, absent; 1, simple; 2, weak intermediate; 4, rich intermediate. Recruitment data not available for patients 4, 8 and 12. CMAP, compound muscle action potential; CV, conduction velocity; FP, fibrillation potentials; LP, slow potentials of denervation; M, myopathy; N, neuropathy; NM, neuromyopathy.